Sponsor
1 Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the reduce randomized clinical trial JAMA, May 24, 2013 Evidence Based Medicine
2 Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancer Annals of Oncology, May 21, 2013
3 Cardiovascular Safety of Inhaled Long-Acting Bronchodilators in Individuals With Chronic Obstructive Pulmonary Disease JAMA Internal Medicine, May 21, 2013 Evidence Based Medicine
4 Clinical ascertainment of health outcomes among adults treated for childhood cancer JAMA, June 12, 2013 Evidence Based Medicine
5 Association between eosinophilic airway inflammation and persistent airflow limitation Journal of Asthma, May 24, 2013
6 An assessment of the effects of iyengar yoga practice on the health-related quality of life of patients with chronic respiratory diseases: A pilot study, Canadian Respiratory Journal, May 22, 2013
7 Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease JAMA, June 12, 2013 Evidence Based Medicine
8 Diet and vitamin D as risk factors for lung impairment and COPD Translational Research, The Journal of Laboratory and Clinical Medicine, May 23, 2013
9
Can an airway challenge test predict respiratory diseases? A population-based international study
The Journal of Allergy and Clinical Immunology, May 22, 2013
Exclusive Author Commentary
10 Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting {beta}2 agonist: observational matched cohort study (PATHOS) British Medical Journal, June 7, 2013 Evidence Based Medicine
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor